Scott Duncan

Scott Duncan is an experienced professional in the pharmaceutical industry, currently serving as the Process Development and Manufacturing Lead for Small Molecules at the Bill & Melinda Gates Medical Research Institute. With a strong background in chemistry, Scott has held significant positions including CMC Consultant at CMC Reimagined, Sr. Director of CMC at Roivant Sciences, and Director of CMC at Centrexion Therapeutics Corp. Additionally, Scott has served as the Director of Chemistry and Technical Operations at Stealth BioTherapeutics. Scott holds a Ph.D. in Organic Chemistry from the University of Wisconsin-Madison and a Bachelor of Science in Chemistry from Mercer University.